Westbourne Investment Advisors, Inc. Bausch Health Companies Inc. Transaction History

Westbourne Investment Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 02, 2021	SELL	$27.43 - $32.7 $305,295 - $363,951	-11,130 Closed	0 $0
Q1 2021 Apr 27, 2021	SELL	$21.37 - $34.38 $376,005 - $604,916	-17,595 Reduced 61.25%	11,130 $353,000
Q4 2020 Jan 22, 2021	BUY	$15.31 - $21.12 $41,337 - $57,024	2,700 Added 10.37%	28,725 $597,000
Q3 2020 Nov 03, 2020	BUY	$14.88 - $20.13 $136,598 - $184,793	9,180 Added 54.5%	26,025 $404,000
Q2 2020 Jul 14, 2020	BUY	$13.31 - $20.51 $50,045 - $77,117	3,760 Added 28.74%	16,845 $308,000
Q1 2020 Apr 21, 2020	BUY	$12.98 - $30.25 $14,278 - $33,275	1,100 Added 9.18%	13,085 $203,000
Q4 2019 Jan 23, 2020	BUY	$18.89 - $31.89 $226,396 - $382,201	11,985 New	11,985 $359,000

258

255M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.83B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Westbourne Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Westbourne Investment Advisors, Inc. with notifications on news.